Table 1.
Baseline characteristics of the 22 patients.
| General characteristics of the 22 patients | |
| Age, years | 66 [63–73] |
| Male sex | 16/22 (73%) |
| Overweight (BMI from 25 to <30 kg/m2) | 9/22 (41%) |
| Obese (BMI > 30 kg/m2) | 9/22 (41%) |
| Type 2 diabetes | 3/22 (14%) |
| Hypertension | 11/22 (50%) |
| Currently smocker patient | 2/22 (9%) |
| Cardiovascular disease | 3/22 (14%) |
| Chronic kidney failure | 6/22 (27%) |
| Kidney graft | 2/22 (9%) |
| Cancer | 6/22 (27%) |
| SAPS II, points | 58 [47–67] |
| Duration of mechanical ventilation, days | 16 [8–23] |
| NeuroMuscular Blocking Drugs (NMBD) | 20/22 (91%) |
| Prone position | 14/22 (64%) |
| Steroid therapy | 11/22 (50%) |
| Veno-venous Extracorporeal Membrane Oxygenation | 5/22 (23%) |
| Laboratory results collected at admission | |
| Leukocytes, 109/L | 8.5 [5.6–14.1] |
| Lymphocytes, 109/L | 0.4 [0.2–0.5] |
| CRP, mg/L | 142.1 [110.9–182.2] |
| PCT, μg/L | 1.2 [0.48–3.7] |
| LDH, U/L | 511.5 [449.2–562.5] |
| Arterial lactate, mmol/L | 1.4 [1–2.3] |
| D-dimeres, μg/L | 2320 [980–4050] |
Data are n (%) or mean (SD) unless otherwise stated. SAPS 2, simplified acute physiological score; CRP, C-reactive protein; PCT, procalcitonin; LDH, lactate dehydrogenase.